Kymos and ISGlobal join efforts to STOP parasitic diseases in Africa

“Kymos is a group with the highest ethical standards. This is not a PR statement but our day-to-day philosophy” Dr. Carles Celma, Scientific Director at Kymos stresses. “It was our pleasure to take an active role in the STOP project for the treatment of intestinal parasites in developing countries as soon as ISGlobal approached us.” (...)

Read more

By |2022-07-19T13:49:13+02:00November 30th, 2021|News|Comments Off on Kymos and ISGlobal join efforts to STOP parasitic diseases in Africa

Exceptional CPHI keeps business running

Finally, after a two-year break, we were able to attend CPhI again and meet our contacts in person. Despite the pandemic, cancellations and against many odds, this CPHI far exceeded all our expectations, and we thank all our clients and partners, but also the organisers and our team, who faced the challenge and made CPHI (...)

Read more

By |2022-06-28T14:32:32+02:00November 18th, 2021|News|Comments Off on Exceptional CPHI keeps business running

Microbiology: Adding Value to a Full Service

At Kymos, recognized leader in comprehensive laboratory testing, we are privileged to have an entire department dedicated to microbiological testing for sterile and non-sterile API’s and drug products. Karen Reboulaz, Manager of the Microbiology Department, shares with us a deeper insight in her team’s work and the reasons why a significantly increasing number of clients (...)

Read more

By |2022-07-19T14:55:19+02:00November 3rd, 2021|News|Comments Off on Microbiology: Adding Value to a Full Service

KYMOS at CPhI Worldwide 2021 in Milan

The time for CPhI 2021 Milan is finally here after 2020's hiatus and Kymos is sending an even larger contingent of 12 experts to repeat our success back in CPhI 2019 Frankfurt. Covering every step of the supply chain, CPhI is the perfect place to network and Kymos is an ideal multidisciplinary partner to outsource (...)

Read more

By |2022-06-28T14:32:33+02:00October 19th, 2021|News|Comments Off on KYMOS at CPhI Worldwide 2021 in Milan

Analytical Development & Validation: The Entry Gate Of Your Project

Rosa Latorre, PhD in Analytical Chemistry and Director of the Analytical Development and Validation Department at Kymos, started her career in big pharmaceutical multinationals such as Merck, Grifols and Ipsen before joining Kymos - which in 2009 was a much smaller CRO than today - to provide analytical services for those global players she had (...)

Read more

By |2022-07-19T14:57:09+02:00October 7th, 2021|News|Comments Off on Analytical Development & Validation: The Entry Gate Of Your Project

Pharmaprogress’ First-Hand Nitrosamine Experience: Pushing the Analytical Envelope

We are pleased to announce that Dr Luca Gramaccioni, General Site Manager at Kymos Italian Site Pharmaprogress, has been asked to share his analytical experience on nitrosamines in yet another webinar – this time the AFI Symposium 2021 hosted by the Associazione Farmaceutici Industria on September 24th. In anticipation for the event, he and Dr (...)

Read more

By |2022-07-19T14:57:51+02:00September 28th, 2021|News|Comments Off on Pharmaprogress’ First-Hand Nitrosamine Experience: Pushing the Analytical Envelope

Percutaneous Absorption: Like a Second Skin

An important function of the skin is to protect the body from the environment, and it is normally a very effective barrier against external substances. In some cases, however, penetration of active substances (API) into the skin is desired to provide a therapeutic effect. Hence, manufacturers of pharmaceutical topical products must test how well (...)

Read more

By |2022-07-19T13:54:14+02:00July 16th, 2021|News|Comments Off on Percutaneous Absorption: Like a Second Skin

20 Years Growing Together

Not many companies can celebrate 20 years of collaboration after reporting their best revenues ever and having become a successful multinational group, but contract research organization KYMOS and top biopharmaceutical innovator PHARMAMAR are just going to do that. How the evolution of pharmaceutical outsourcing over the last two decades has changed the trajectory of these (...)

Read more

By |2022-07-19T14:58:49+02:00June 28th, 2021|News|Comments Off on 20 Years Growing Together

Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines

Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines Luca Gramaccioni, Site General Manger at Kymos Pharmaprogress, was a guest speaker at the 40th AEFI symposium last May 11th. He presented “Nitrosamines: How to face the analytical challenges for step 2” at a Round Table alongside other experts from AEMPs, AZIERTA and AGILENT. In (...)

Read more

By |2022-07-19T15:03:34+02:00May 10th, 2021|News|Comments Off on Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines

Your Stability Studies in Safe Hands

In recent years Kymos has experienced a surge in demand from drug manufacturers in need of a reliable outsourcing partner for their stability programmes. Kymos responded by making a major investment to build new climatic chambers in their sites in Spain and Italy to reach today’s 100m³ of storage capacity for all conditions corresponding (...)

Read more

By |2022-07-19T15:26:07+02:00April 26th, 2021|News|Comments Off on Your Stability Studies in Safe Hands